Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms
Journal of Clinical Oncology, 05/17/2012Nardi V et al.
Acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) diagnosed in the past decade in patients after receiving XRT alone differ from therapy–related myeloid neoplasms (t–MN) occurring after chemotherapy/combined–modality therapy (C/CMT) and share genetic features and clinical behavior with de novo AML/MDS. The results suggest that post–external–beam radiation (XRT) MDS/AML may not represent a direct consequence of radiation toxicity and warrant a therapeutic approach similar to de novo disease.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.